BioSight
Companies
PERRIGO Co plc logo

PRGO

NYSEDUBLIN 2, L2
PERRIGO Co plc

Perrigo Co plc is a commercial-stage company operating across consumer healthcare and specialty pharmaceuticals with a diversified portfolio of over-the-counter products and prescription medications, though specific therapeutic areas and drug modalities are not detailed in this excerpt. The company has undertaken significant portfolio restructuring including the divestment of its Dermacosmetics branded business and prior sales of its HRA Rare Diseases Business and Rx business, indicating a shift in strategic focus that is not fully characterized in the available information.

Price history not yet available for PRGO.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar